Eric Hughes
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 43
- Hepatitis C virus research 43
- Epidemiology 14
- Hepatitis B Virus Studies 8
- Liver Disease Diagnosis and Treatment 6
- Co-authors
- Peter Cresswell (5 shared papers)Peter Cresswell (3 shared papers)Fiona McPhee (18 shared papers)Craig Hammond (1 shared paper)Robert J. Fontana (4 shared papers)Hiroki Ishikawa (8 shared papers)Kazuaki Chayama (7 shared papers)Hiromitsu Kumada (7 shared papers)
- Journals
- Journal of Hepatology (20 papers)Hepatology (5 papers)Antiviral Therapy (4 papers)Liver International (3 papers)Clinical Pharmacokinetics (3 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Eric Hughes
62 papers receiving 2.9k citations
Eric Hughes's Hit Papers
Peers
Comparison fields: 5 of 93
- Hepatology 1.8k
- Epidemiology 1.2k
- Immunology 628
- Infectious Diseases 406
- Virology 52
Countries citing papers authored by Eric Hughes
This map shows the geographic impact of Eric Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Hughes more than expected).
Fields of papers citing papers by Eric Hughes
This network shows the impact of papers produced by Eric Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Hughes. The network helps show where Eric Hughes may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Hughes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence Hit paper breakdown → | 2016 | 331 |
| 2 | 2011 | 256 | |
| 3 | 2009 | 252 | |
| 4 | 1997 | 249 | |
| 5 | 1992 | 188 | |
| 6 | 2012 | 180 | |
| 7 | 1998 | 162 | |
| 8 | 1999 | 139 | |
| 9 | 2013 | 112 | |
| 10 | 2015 | 69 | |
| 11 | 1996 | 59 | |
| 12 | 2014 | 58 | |
| 13 | 2012 | 58 | |
| 14 | 2012 | 51 | |
| 15 | 2012 | 45 | |
| 16 | 2011 | 39 | |
| 17 | 2013 | 36 | |
| 18 | 2015 | 35 | |
| 19 | 2013 | 35 | |
| 20 | 1998 | 35 |
About Eric Hughes
Eric Hughes is a scholar working on Hepatology, Epidemiology, Immunology, Infectious Diseases and Molecular Biology, having authored 62 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (43 papers), Hepatitis B Virus Studies (8 papers), Systemic Lupus Erythematosus Research (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (6 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.2k citations), Immunology (628 citations), Infectious Diseases (406 citations) and Virology (52 citations). Eric Hughes has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Peter Cresswell, Peter Cresswell, Fiona McPhee, Craig Hammond, Robert J. Fontana, Hiroki Ishikawa, Kazuaki Chayama, Hiromitsu Kumada, Joji Toyota and Yoshiyasu Karino. Their work appears in journals such as Journal of Hepatology, Hepatology, Antiviral Therapy, Liver International and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.